Form 483

US Specialty Formulations LLC Form 483, 2017-08-29

FDA issued a Form 483 to US Specialty Formulations LLC on 2017-08-29 with 7 public-safe observations.

483· Form 483 issuedHuman Drugs7 observations

US Specialty Formulations LLC · Allentown, United States · Issued August 29, 2017

Overview

  • 7 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

29 Aug 2017
21 CFR 211.165(a)

Testing and release for distribution

Cited by James M Mason, John M Mastalski

29 Aug 2017
21 CFR 211.194(a)(8)

Identification of Person Performing Review of Lab Records

Cited by James M Mason, John M Mastalski

29 Aug 2017
21 CFR 211.28(a)

Clothing appropriate for duties performed

Cited by James M Mason, John M Mastalski

29 Aug 2017
21 CFR 211.42(c)(10)(v)

Cleaning System

Cited by James M Mason, John M Mastalski

29 Aug 2017
21 CFR 211.67(a)

Cleaning / Sanitizing / Maintenance

Cited by James M Mason, John M Mastalski

Inspected site

USUS Specialty Formulations LLCAllentown, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.165(a)Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)(8)Cited across public-safe Form 483 observations1x
21 CFR 211.28(a)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(v)Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x
FDCA 503B(a)(10)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 7 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere